NCT02315092

Brief Summary

The current trial aims to compare the assessment of diabetic foot ulcers by fluorescence image guidance to standard practice. The device will be used to acquire fluorescence images of diabetic foot ulcers: when wounds are illuminated by violet/blue light, most pathogenic bacterial species emit a unique red fluorescence signal. The device is intended to be used as part of the clinical assessment process, which may include visual assessment, signs of heat or high temperature, the presence of exudate, and redness in the area. Images will guide the clinician to inspect, sample or further evaluate areas where fluorescing bacteria is present. This study will allow us to determine the benefit of fluorescence image-guided procedure as compared to standard clinical practice to assess bacterial burden in diabetic foot ulcers. Microbiological swabbing under standard practice and fluoresce-guided imaging will be performed in order to compare the two techniques.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

December 9, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 11, 2014

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

February 13, 2018

Status Verified

February 1, 2018

Enrollment Period

2.1 years

First QC Date

December 9, 2014

Last Update Submit

February 12, 2018

Conditions

Keywords

Diabetic Foot UlcersBacteriaFluorescence

Outcome Measures

Primary Outcomes (2)

  • Correlation of localized fluorescence signals in acquired images with microbiological samples

    Microbiological swabs will be taking from fluorescence positive regions to correlate with bacterial presence

    At study visit (only one study visit)

  • Comparison of number/variety of bacteria obtained by fluorescence-guided sampling vs. standard practice

    Microbiological swabs will be taking from the wound using standard practice and following fluorescence-image guidance

    At study visit (only one study visit)

Secondary Outcomes (1)

  • Assessment of the clinical functionality of the K2 Imaging Device

    At study visit (only one study visit)

Study Arms (1)

Diabetic foot ulcers

Patients who present with diabetic foot ulcers will undergo fluorescence imaging.

Device: Fluorescence Imaging

Interventions

Wounds will be imaged using violet light (405 nm) illumination to locate areas with bacterial presence to guide swabbing.

Diabetic foot ulcers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who present with a diabetic foot ulcer and are receiving standard wound care treatment.

You may qualify if:

  • Male or female who present with a diabetic foot ulcer and are receiving standard wound care treatment.
  • years and older

You may not qualify if:

  • Treatment with an investigational drug within 1 month before study enrolment
  • Inability to consent
  • Any contra-indication to routine wound care and/or monitoring

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Judy Dan Research and Treatment Centre

Toronto, Ontario, M2R1N5, Canada

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Microbiological samples (skin and wound swabs)

MeSH Terms

Conditions

Diabetic Foot

Interventions

Optical Imaging

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsDiabetes MellitusEndocrine System DiseasesDiabetic Neuropathies

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Ralph S DaCosta, PhD

    Princess Margaret Cancer Centre, University Health Network

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientist

Study Record Dates

First Submitted

December 9, 2014

First Posted

December 11, 2014

Study Start

December 1, 2014

Primary Completion

January 1, 2017

Study Completion

January 1, 2017

Last Updated

February 13, 2018

Record last verified: 2018-02

Locations